Literature DB >> 32848209

Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA.

Maturada Patchsung1, Krittapas Jantarug1, Archiraya Pattama2, Kanokpol Aphicho1, Surased Suraritdechachai1, Piyachat Meesawat1, Khomkrit Sappakhaw1, Nattawat Leelahakorn1, Theerawat Ruenkam1, Thanakrit Wongsatit1, Niracha Athipanyasilp2, Bhumrapee Eiamthong1, Benya Lakkanasirorat1, Thitima Phoodokmai1, Nootaree Niljianskul3, Danaya Pakotiprapha4, Sittinan Chanarat4, Aimorn Homchan4, Ruchanok Tinikul4, Philaiwarong Kamutira4, Kochakorn Phiwkaow1, Sahachat Soithongcharoen1, Chadaporn Kantiwiriyawanitch1, Vinutsada Pongsupasa1, Duangthip Trisrivirat1, Juthamas Jaroensuk1, Thanyaporn Wongnate1, Somchart Maenpuen5, Pimchai Chaiyen1, Sirichai Kamnerdnakta6, Jirawat Swangsri6, Suebwong Chuthapisith6, Yongyut Sirivatanauksorn6, Chutikarn Chaimayo2, Ruengpung Sutthent2, Wannee Kantakamalakul2, Julia Joung7,8,9,10, Alim Ladha7,8,9,10, Xin Jin8,9,11,12, Jonathan S Gootenberg9,13, Omar O Abudayyeh9,13, Feng Zhang7,8,9,10,13,14, Navin Horthongkham15, Chayasith Uttamapinant16.   

Abstract

Nucleic acid detection by isothermal amplification and the collateral cleavage of reporter molecules by CRISPR-associated enzymes is a promising alternative to quantitative PCR. Here, we report the clinical validation of the specific high-sensitivity enzymatic reporter unlocking (SHERLOCK) assay using the enzyme Cas13a from Leptotrichia wadei for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-the virus that causes coronavirus disease 2019 (COVID-19)-in 154 nasopharyngeal and throat swab samples collected at Siriraj Hospital, Thailand. Within a detection limit of 42 RNA copies per reaction, SHERLOCK was 100% specific and 100% sensitive with a fluorescence readout, and 100% specific and 97% sensitive with a lateral-flow readout. For the full range of viral load in the clinical samples, the fluorescence readout was 100% specific and 96% sensitive. For 380 SARS-CoV-2-negative pre-operative samples from patients undergoing surgery, SHERLOCK was in 100% agreement with quantitative PCR with reverse transcription. The assay, which we show is amenable to multiplexed detection in a single lateral-flow strip incorporating an internal control for ribonuclease contamination, should facilitate SARS-CoV-2 detection in settings with limited resources.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32848209     DOI: 10.1038/s41551-020-00603-x

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   25.671


  118 in total

Review 1.  Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures.

Authors:  Gajanan Sampatrao Ghodake; Surendra Krushna Shinde; Avinash Ashok Kadam; Rijuta Ganesh Saratale; Ganesh Dattatraya Saratale; Asad Syed; Abdallah M Elgorban; Najat Marraiki; Dae-Young Kim
Journal:  Biosens Bioelectron       Date:  2021-01-04       Impact factor: 10.618

Review 2.  Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.

Authors:  Seyed Hamid Safiabadi Tali; Jason J LeBlanc; Zubi Sadiq; Oyejide Damilola Oyewunmi; Carolina Camargo; Bahareh Nikpour; Narges Armanfard; Selena M Sagan; Sana Jahanshahi-Anbuhi
Journal:  Clin Microbiol Rev       Date:  2021-05-12       Impact factor: 26.132

Review 3.  HEPN RNases - an emerging class of functionally distinct RNA processing and degradation enzymes.

Authors:  Monica C Pillon; Jacob Gordon; Meredith N Frazier; Robin E Stanley
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-12-22       Impact factor: 8.250

Review 4.  Exploiting DNA Endonucleases to Advance Mechanisms of DNA Repair.

Authors:  Marlo K Thompson; Robert W Sobol; Aishwarya Prakash
Journal:  Biology (Basel)       Date:  2021-06-14

Review 5.  The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2.

Authors:  Maged G Hemida
Journal:  J Med Virol       Date:  2021-03-26       Impact factor: 2.327

6.  Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells.

Authors:  Alejandro Méndez-Mancilla; Hans-Hermann Wessels; Mateusz Legut; Anastasia Kadina; Megumu Mabuchi; John Walker; G Brett Robb; Kevin Holden; Neville E Sanjana
Journal:  Cell Chem Biol       Date:  2021-08-02       Impact factor: 8.116

7.  Optimization and Clinical Evaluation of a Multi-Target Loop-Mediated Isothermal Amplification Assay for the Detection of SARS-CoV-2 in Nasopharyngeal Samples.

Authors:  Foteini Roumani; Sarah Azinheiro; Hugo Sousa; Ana Sousa; Mafalda Timóteo; Tatiana Varandas; Daniela Fonseca-Silva; Inês Baldaque; Joana Carvalho; Marta Prado; Alejandro Garrido-Maestu
Journal:  Viruses       Date:  2021-05-19       Impact factor: 5.048

8.  Harnessing recombinase polymerase amplification for rapid multi-gene detection of SARS-CoV-2 in resource-limited settings.

Authors:  Dounia Cherkaoui; Da Huang; Benjamin S Miller; Valérian Turbé; Rachel A McKendry
Journal:  Biosens Bioelectron       Date:  2021-05-14       Impact factor: 10.618

Review 9.  COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19.

Authors:  Yan Zhan; Xiang-Ping Li; Ji-Ye Yin
Journal:  Int J Biol Sci       Date:  2021-05-13       Impact factor: 6.580

10.  Translating daily COVID-19 screening into a simple glucose test: a proof of concept study.

Authors:  Ran Liu; Yuansheng Hu; Ying He; Tian Lan; Jingjing Zhang
Journal:  Chem Sci       Date:  2021-05-25       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.